AT115862T - Tocols as a vaccine adjuvant. - Google Patents

Tocols as a vaccine adjuvant.


Publication number
AT115862T AT90200127T AT90200127T AT115862T AT 115862 T AT115862 T AT 115862T AT 90200127 T AT90200127 T AT 90200127T AT 90200127 T AT90200127 T AT 90200127T AT 115862 T AT115862 T AT 115862T
Prior art keywords
vaccine adjuvant
Prior art date
Application number
Other languages
German (de)
Lammert Cornelius
Eric Onno Rijke
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL8900277 priority Critical
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AT115862T publication Critical patent/AT115862T/en



    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
AT90200127T 1989-02-04 1990-01-18 Tocols as a vaccine adjuvant. AT115862T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL8900277 1989-02-04

Publications (1)

Publication Number Publication Date
AT115862T true AT115862T (en) 1995-01-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT90200127T AT115862T (en) 1989-02-04 1990-01-18 Tocols as a vaccine adjuvant.

Country Status (15)

Country Link
US (2) US5650155A (en)
EP (1) EP0382271B1 (en)
JP (1) JP2892739B2 (en)
KR (1) KR0162646B1 (en)
CN (1) CN1056085C (en)
AT (1) AT115862T (en)
AU (1) AU633043B2 (en)
CA (1) CA2008856C (en)
DE (2) DE69015222D1 (en)
DK (1) DK0382271T3 (en)
ES (1) ES2068989T3 (en)
GR (1) GR3015438T3 (en)
HU (1) HU206989B (en)
NZ (1) NZ232354A (en)
ZA (1) ZA9000512B (en)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US6197311B1 (en) 1991-07-25 2001-03-06 Idec Pharmaceuticals Corporation Induction of cytotoxic T-lymphocyte responses
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
AU755502C (en) * 1999-03-24 2003-08-14 Secretary Of State For Defence, The Immunostimulants
PT1326638E (en) 2000-10-18 2008-02-06 Glaxosmithkline Biolog Sa Vaccines against cancers
GB0025577D0 (en) * 2000-10-18 2000-12-06 Smithkline Beecham Biolog Vaccine
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
TW200722101A (en) 2005-03-23 2007-06-16 Glaxosmithkline Biolog Sa Novel composition
WO2007028823A1 (en) * 2005-09-09 2007-03-15 Intervet International B.V. Pcv-2 vaccine
DK179025B1 (en) 2005-09-16 2017-08-28 Intervet Int Bv fish vaccine
TW201350129A (en) 2005-12-22 2013-12-16 Glaxosmithkline Biolog Sa Streptococcus pneumoniae immunogenic composition comprising capsular saccharide conjugates, vaccine and kit comprising the same and uses thereof
EP2433648A3 (en) 2006-10-12 2012-04-04 GlaxoSmithKline Biologicals S.A. Vaccine comprising an oil in water emulsion adjuvant
KR101151202B1 (en) 2006-10-12 2012-06-11 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising an oil in water emulsion adjuvant
SG170090A1 (en) 2006-03-30 2011-04-29 Glaxosmithkline Biolog Sa Immunogenic composition
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
EA200900024A1 (en) 2006-07-17 2009-06-30 Глаксосмитклайн Байолоджикалс С.А. Anti-throat vaccine
CN103357003A (en) 2006-09-07 2013-10-23 葛兰素史密丝克莱恩生物有限公司 Vaccine
HUE037808T2 (en) 2006-09-26 2018-09-28 Infectious Disease Res Institute Vaccine composition containing synthetic adjuvant
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
US9452209B2 (en) * 2007-04-20 2016-09-27 Glaxosmithkline Biologicals Sa Influenza vaccine
EA201391788A1 (en) 2007-06-26 2014-08-29 Глаксосмитклайн Байолоджикалс С.А. Vaccine containing conjugates of capsular polysaccharides streptococcus pneumoniae
BRPI0816134A2 (en) 2007-08-28 2015-07-28 Université de Liège Herpesvirus, DNA sequence, vector, cell, virus, method for producing infectious particles, infectious particles, vaccine, use of herpesvirus or DNA sequence or vector or infectious particles, and method for preventive and / or treatment. treatment of a disease.
US7741418B2 (en) * 2007-12-31 2010-06-22 Bridgestone Corporation Process for producing polydienes
EP2271360B1 (en) 2008-04-16 2015-09-23 GlaxoSmithKline Biologicals S.A. Vaccine
TWI551295B (en) 2008-04-18 2016-10-01 Intervet Int Bv Guard against Lawsonia intracellularis (Lawsonia intracellularis) vaccines
UA100047C2 (en) * 2008-04-18 2012-11-12 Интервет Интернешонал Б.В. Vaccine for the protection against lawsonia intracellularis
TWI449533B (en) 2008-04-18 2014-08-21 Intervet Int Bv Vaccine for protection against lawsonia intracellularis, mycoplasma hyopneumoniae and porcine circo virus
ES2567712T3 (en) 2008-04-28 2016-04-26 Intervet International B.V. New Avian Astroviruses
EP2328614A1 (en) * 2008-08-06 2011-06-08 Novartis AG Microparticles for use in immunogenic compositions
WO2010079081A1 (en) 2009-01-07 2010-07-15 Glaxosmithkline Biologicals S.A. Methods for recovering a virus or a viral antigen produced by cell culture
EP2393922A1 (en) 2009-02-06 2011-12-14 GlaxoSmithKline Biologicals S.A. Purification of virus or viral antigens by density gradient ultracentrifugation
MX360448B (en) 2009-06-05 2018-11-01 Infectious Disease Res Institute Synthetic glucopyranosyl lipid adjuvants.
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US9341623B2 (en) 2009-09-25 2016-05-17 Glaxosmithkline Biologicals Sa Immunodiffusion assay for influenza virus
GB0918830D0 (en) 2009-10-27 2009-12-09 Glaxosmithkline Biolog Niederl Process
GB0919117D0 (en) 2009-10-30 2009-12-16 Glaxosmithkline Biolog Sa Process
KR20130048208A (en) 2010-03-11 2013-05-09 이뮨 디자인 코포레이션 Vaccines for pandemic influenza
GB201006324D0 (en) 2010-04-15 2010-06-02 Glaxosmithkline Biolog Sa Vaccine
EP2566958B1 (en) 2010-05-03 2015-12-30 GlaxoSmithKline Biologicals S.A. Method for inactivating influenza virus
GB201009673D0 (en) 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
GB201009676D0 (en) 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
ES2635014T3 (en) 2010-10-15 2017-10-02 Glaxosmithkline Biologicals S.A. Cytomegalovirus gB antigen
EP2629794B1 (en) 2010-10-18 2017-06-07 Intervet International B.V. Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
DK2651436T3 (en) 2010-12-14 2016-06-20 Glaxosmithkline Biologicals Sa Mycobactery antigen composition.
JP5980810B2 (en) 2010-12-29 2016-09-07 インターベット インターナショナル ベー. フェー. Canine babesiosis vaccine antigen
CN103596586A (en) 2011-04-08 2014-02-19 免疫设计公司 Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US20120288515A1 (en) 2011-04-27 2012-11-15 Immune Design Corp. Synthetic long peptide (slp)-based vaccines
AU2012306282A1 (en) 2011-09-08 2014-03-20 Umc Utrecht Holding B.V. Vaccine based on Staphylococcal superantigen-like 3 protein (SSL3)
US20140348875A1 (en) 2011-12-30 2014-11-27 University of Liege, Faculty of Veterinary Medicine Koi herpesvirus vaccine
AR089868A1 (en) 2012-02-03 2014-09-24 Animal Health Inst eimeria vector vaccine for campylobacter jejuni
WO2013173590A1 (en) 2012-05-16 2013-11-21 Immune Design Corp. Vaccines for hsv-2
CN104884081A (en) 2012-12-05 2015-09-02 葛兰素史密丝克莱恩生物有限公司 The immunogenic composition
KR20150137085A (en) 2013-03-26 2015-12-08 더 피르브라이트 인스티튜트 Stabilised fmdv capsids
ES2643031T3 (en) 2013-03-29 2017-11-21 Intervet International B.V. Rhipicephalus Tick Vaccine
MX2015014431A (en) 2013-04-18 2016-06-02 Immune Design Corp Gla monotherapy for use in cancer treatment.
WO2014191445A1 (en) 2013-05-31 2014-12-04 Intervet International B.V. Scale drop disease (sdd) causative virus and derivatives thereof
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
US10392603B2 (en) 2013-08-30 2019-08-27 The Chemo-Sero-Therapeutic Research Institute Method of viral purification
CR20160369A (en) 2014-01-21 2016-10-05 Immune Desing Corp Compositions for use in the treatment of allergic conditions
CN104013955B (en) * 2014-06-18 2016-02-24 中国科学院过程工程研究所 Which does not contain a surfactant oil in water emulsions and uses thereof
MX2016017094A (en) 2014-06-25 2017-05-03 Glaxosmithkline Biologicals Sa Clostridium difficile immunogenic composition.
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
EP3234113B1 (en) 2014-12-16 2019-01-23 GlaxoSmithKline Biologicals S.A. A method for a large scale virus purification
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201603625D0 (en) 2016-03-02 2016-04-13 Glaxosmithkline Biolog Sa Novel influenza antigens
WO2017167768A1 (en) 2016-03-28 2017-10-05 Glaxosmithkline Biologicals S.A. Novel vaccine composition
WO2018232257A1 (en) 2017-06-15 2018-12-20 Infectious Disease Research Institute Nanostructured lipid carriers and stable emulsions and uses thereof
WO2019090238A1 (en) 2017-11-03 2019-05-09 Takeda Vaccines, Inc. Zika vaccines and immunogenic compositions, and methods of using the same
WO2019110481A1 (en) 2017-12-04 2019-06-13 Intervet International B.V. Vaccination with replicon particles and oil adjuvant

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant
NL8301996A (en) * 1983-06-06 1985-01-02 Duphar Int Res A method of preparing adjuvanted live vaccines and adjuvanted live vaccines thus obtained.
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US5023271A (en) * 1985-08-13 1991-06-11 California Biotechnology Inc. Pharmaceutical microemulsions
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
AU596581B2 (en) * 1986-04-15 1990-05-10 Sansho Seiyaku Co., Ltd. Topical agents for inhibiting the melanin generation
ZA8702532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines

Also Published As

Publication number Publication date
HU206989B (en) 1993-03-01
GR3015438T3 (en) 1995-06-30
ES2068989T3 (en) 1995-05-01
US5650155A (en) 1997-07-22
EP0382271B1 (en) 1994-12-21
DE69015222T2 (en) 1995-05-04
NZ232354A (en) 1991-09-25
ZA9000512B (en) 1990-11-28
JP2892739B2 (en) 1999-05-17
DK0382271T3 (en) 1995-05-01
JPH02250835A (en) 1990-10-08
DE69015222D1 (en) 1995-02-02
CN1044594A (en) 1990-08-15
AU4897590A (en) 1990-08-09
KR0162646B1 (en) 1998-12-01
CN1056085C (en) 2000-09-06
HU900653D0 (en) 1990-04-28
CA2008856C (en) 2001-06-19
AU633043B2 (en) 1993-01-21
US5667784A (en) 1997-09-16
HUT56285A (en) 1991-08-28
CA2008856A1 (en) 1990-08-04
EP0382271A1 (en) 1990-08-16

Similar Documents

Publication Publication Date Title
DE69004768T2 (en) Walkers support.
NO905350L (en) Utporsjoneringsapparat.
NO902412L (en) Laparoskopikanyle.
NO900330L (en) Roekeartikler.
NO943920D0 (en) vaccine adjuvant
NO930938D0 (en) improved vaccines
NO902289D0 (en) Blodproeve-rower.
NO910517D0 (en) Perfluorovinyl.
NO900412L (en) Sproeytespiss.
DE3787663T2 (en) Vaccine.
NO902134L (en) Drink-smaksettingskasett.
NO900448D0 (en) Fluidstroemningsmaaler.
FI922313A (en) Adjustably Bælte which is intended Foer absorbed berande klaedesplagg.
NO894248D0 (en) Broennverktoey.
DE69019164T2 (en) Improved meningococcal polysaccharidkonjugatvakzin.
NO895225L (en) Trykkfoeler.
NO900089D0 (en) Smoeremidler for kjoelekompressorer.
DE69126606T2 (en) vaccine
NO901778D0 (en) Tv-play machine.
DE68909934D1 (en) Helmet.
NO905379L (en) Matte-holder.
NO901002L (en) Low-cost wet-to-wet trykkavfoelerpakke.
DE69022290D1 (en) Live vaccines.
NO913717D0 (en) Crutches.
NO890927L (en) Vacuum avloepssystem.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time